EP3240551A4 - Methods of treating hematological disorders, solid tumors, or infectious
diseases using natural killer cells - Google Patents EP3240551A4 - Methods of treating …

Provided herein are methods of treating acute myeloid leukemia (AML) and multiple
myeloma (MM) by administering an effective amount of a cell population comprising natural …

Methods of employing bis (thio-hydrazide amides) to increase NK cell activity in a Subject in
need thereof, eg, a Subject with an infection or an immunodeficiency, are pro vided such that …

US20090068141A1 - Autologous natural killer cells and lymphodepleting chemotherapy for the
treatment of cancer - Google Patents US20090068141A1 - Autologous natural killer cells and …

2018-08-23 Assigned to ANTHROGENESIS CORPORATION reassignment
ANTHROGENESIS CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE …

FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-
amino-3-phenylpropanoyl] amino]-3-phenylpropanoyl] amino]-4-methylpentanoyl] amino] …

US9623082B2 - Methods and compositions for natural killer cells - Google Patents
US9623082B2 - Methods and compositions for natural killer cells - Google Patents Methods and …

Methods of ex-vivo culture of natural killer (NK) cells are provided and, more particularly,
methods for enhancing propagation and/or functionality of NK cells by treating the cells with …

2. BACKGROUND 0003 Placental perfusate comprises a collection of pla cental cells
obtained by passage of a perfusion Solution through the placental vasculature, and …

Provided herein are methods of producing natural killer cells using a two-step expansion
and differentiation method. Also provided herein are methods of suppressing tumor cell …